Publications
Preprints and pre-reviewed scientific papers about SARS-COV-2 seroprevalence studies.
Prevalence of IgG and IgM antibodies to SARS-CoV-2 among clinic staff and patients
The coronavirus disease 2019 (COVID-19) is now a pandemic with devastating social and economic consequences.
SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission
The extent of SARS-CoV-2 transmission among pupils in primary schools and their families is unknown.
Differential occupational risks to healthcare workers from SARS-CoV-2: A prospective observational study
Personal protective equipment (PPE) and social distancing are key measures designed to mitigate the risk of occupational SARS-CoV-2 infection in hospitals.
Serological surveys in Reunion Island of the first hospitalized patients revealed that long-lived immunoglobulin G antibodies specific against SARS-CoV2 virus are rapidly vanishing in severe cases
Both cellular and humoral immunities are critically important to control COVID19 infection but little is known about the kinetics of those responses and, in particular, in patients who will go on to develop a severe form of the disease over several weeks.
Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020
Reported cases of SARS-CoV-2 infection likely underestimate the prevalence of infection in affected communities.
A cross-sectional study of immune seroconversion to SARS-CoV-2 in front-line maternity health professionals
COVID-19, the respiratory disease caused by the SARS-CoV-2, is thought to cause a milder illness in pregnancy with a greater proportion of asymptomatic carriers.
COVID-19 Antibody in Thai Community Hospitals
COVID-19 seroprevalence data has been scarce, especially in less developed countries with a relatively low infection rate.
Seroprevalence of SARS-CoV-2 IgG Specific Antibodies among Healthcare Workers in the Northern Metropolitan Area of Barcelona, Spain, after the first pandemic wave
The rapid spread of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world has caused a global pandemic, infecting millions of individuals worldwide, with an unprecedented impact in health care systems worldwide.
Seroprevalence of SARS-CoV-2 IgG significantly varies with age: results from a mass population screening (SARS-2-SCREEN-CdA).
Castiglione D’Adda is one of the towns earlier and more severely affected by the SARS-CoV-2 epidemic in Lombardy.
A primary care approach to the COVID-19 pandemic: clinical features and natural history of 2,073 suspected cases in the Corona Sao Caetano programme, Sao Paulo, Brazil
Despite most cases not requiring hospital care, there are limited community-based clinical data on COVID-19.
Antibodies against SARS-CoV-2 among health care workers in a country with low burden of COVID-19
Greece is a country with limited spread of SARS-CoV-2 and cumulative infection attack rate of 0.12% (95%CI 0.06%-0.26%).
SARS-CoV-2 exposure, symptoms and seroprevalence in health care workers
SARS-CoV-2 may pose an occupational health risk to health care workers, but the prevalence of infections in this population is unknown.